Alex Oshmyansky, MD, PhD

307 posts

Alex Oshmyansky, MD, PhD banner
Alex Oshmyansky, MD, PhD

Alex Oshmyansky, MD, PhD

@alexosh

CEO / Co-Founder - Mark Cuban Cost Plus Drug Company Entrepreneur, Physician, Mathematician, Filmmaker

Dallas, TX เข้าร่วม Nisan 2009
246 กำลังติดตาม2.5K ผู้ติดตาม
Alex Oshmyansky, MD, PhD
Alex Oshmyansky, MD, PhD@alexosh·
Excited to be speaking at @eMergeAmericas next year!
eMerge Americas@eMergeAmericas

Did you guess the keynote? 👀 We’re proud to announce that Dr. Alex Oshmyansky, Co-founder + CEO of the Mark Cuban Cost Plus Drug Company, will be a 2026 #eMergeAmericas Keynote Speaker. Dr. Oshmyansky is leading a national shift in pharmaceutical pricing transparency and access, redefining how patients and providers navigate the #healthcare system. 📅 April 22–24, 2026 🔗 Register: emergeamericas.com #Globaltech #FloridaTech #MiamiTech #innovation #healthtech #Leadership @alexosh @costplusdrugs

English
1
2
5
364
Alex Oshmyansky, MD, PhD รีทวีตแล้ว
D Magazine
D Magazine@DMagazine·
When he isn’t disrupting the pharmaceutical industry, Dr. Alex Oshmyansky spends time leaning into turns at the racetrack on his motorcycle. l8r.it/9oLh
English
0
1
6
1.2K
BBC
BBC@UnpopularPharm·
@alexosh @tjparker I’m not saying there is lol I think I hold the views that many others have… you are operating essentially as a pbm while trying to march with the anti pbm crowd. When mark says things like “we can’t get that drug” its bs you could use a trad wholesaler you just won’t
English
2
0
1
50
Alex Oshmyansky, MD, PhD
Alex Oshmyansky, MD, PhD@alexosh·
@tjparker @UnpopularPharm If there are better ideas for how help individual patients while helping indy pharmacies and providers while saving the system as a whole money, we are totally open to it! Our strategy now is the best we could create with all the information we currently have.
English
3
0
1
61
Alex Oshmyansky, MD, PhD
Alex Oshmyansky, MD, PhD@alexosh·
@tjparker @UnpopularPharm I know right? 🤣. Cost Plus grew out of a nonprofit and achieving our public health mission is priority #1. We get hundreds of notes from patients who say the were having to skip meals or were thinking about selling their house, etc. before us. Makes it worth while.
English
2
0
1
59
Alex Oshmyansky, MD, PhD
Alex Oshmyansky, MD, PhD@alexosh·
@UnpopularPharm @tjparker I mean, it's kind of an apocalyptic year for indy pharmacies as it is. We are doing the best we can to help patients and pharmacies with the data and analytics we have. Trust me, we aren't making TJ money out of this 😂. Always open to ideas though!
English
2
0
0
60
BBC
BBC@UnpopularPharm·
@alexosh @tjparker And if your hypothesis is wrong? More crunch, more closures
English
1
0
0
26
BBC
BBC@UnpopularPharm·
@alexosh @tjparker Your dispensing fee is lower than Indy’s say is fair and your accessing an acquisition price they also say that they can’t get
English
1
0
0
19
Alex Oshmyansky, MD, PhD
Alex Oshmyansky, MD, PhD@alexosh·
@UnpopularPharm @tjparker Our hypothesis is that indy pharmacies will actually make more money with just a flat markup on all drugs. Yes, atorvastatin and other common drugs become more expensive, but the savings on expensive drugs makes up for it. Pharmacy makes more, payers pay less. PBM loses.
English
1
0
0
36
Alex Oshmyansky, MD, PhD
Alex Oshmyansky, MD, PhD@alexosh·
@UnpopularPharm @tjparker This allows the PBMs to make a lot of money on AWP spread on this small number of products while causing a lot of anguish for patient for leukemia, multiple sclerosis, etc.
English
2
0
0
54
BBC
BBC@UnpopularPharm·
@alexosh @tjparker Alex would love to know how you can be so publicly confident on your transparent “cost” while also unable to commit to what NDC someone will get? Is the “cost” the cost from your owned wholesaler or what your wholesale is buying at
English
1
0
0
24
Alex Oshmyansky, MD, PhD
Alex Oshmyansky, MD, PhD@alexosh·
@tjparker @UnpopularPharm Cool, I look forward to seeing whether an analysis by the former head of Amazon Pharmacy shows they have better pricing than us. 😂 Be well TJ. Enjoy the buyout funds!
English
2
0
0
58
Alex Oshmyansky, MD, PhD
Alex Oshmyansky, MD, PhD@alexosh·
@tjparker @UnpopularPharm The last study I linked as well as several others look at all generic generic drugs. Do you have any data to the contrary other than a secret internal analysis from two years ago? Would be helpful to know if there is any contradictory data.
English
1
0
0
51
TJ Parker⚡️
TJ Parker⚡️@tjparker·
@alexosh @UnpopularPharm I understand there are a number of these studies. I just don’t think any of them are reflective of total costs. At least none that I’ve seen.
English
1
0
0
50
TJ Parker⚡️
TJ Parker⚡️@tjparker·
@alexosh @UnpopularPharm That would be super interesting to see and happy to update my priors if I’m wrong. Does that include +$5/unit for shipping or excluded? How do those numbers change @ increased $12 dispensing fee? I’m not sure my former employer would be thrilled with me sharing internal work.
English
4
0
0
66

ค้นพบ

@eMergeAmericas @costplusdrugs @ddayen @TheProspect @UnpopularPharm @tjparker @elonmusk @BarackObama